CMS, FDA unveil speedier Medicare coverage pathway for breakthrough devices

CMS and the FDA have launched the RAPID Coverage Pathway, a new joint initiative to accelerate Medicare coverage for FDA-designated breakthrough medical devices. The program aims to synchronize FDA review and CMS national coverage determination processes, reducing the lag time between market approval and Medicare reimbursement. This policy shift is intended to speed patient access to novel technologies in cardiology, orthopedics, and oncology. While the direct impact on billing workflows is limited for now, the move signals CMS's continued focus on value-based technology adoption and may influence future coverage decisions for high-cost, innovative procedures.